CSL CEO on Financial Results, Business Outlook

Feb. 12 (Bloomberg) -- Paul Perreault, chief executive officer of CSL Ltd., Australia's biggest pharmaceutical company, talks about its financial results and business outlook. CSL reported a 3.4 percent increase in first-half profit, helped by surging sales of an antidote for the blood-thinner warfarin. Perreault speaks from Melbourne with Angie Lau on Bloomberg Television's "First Up." (Source: Bloomberg)
Zhou's Room to Act Statement `Very Important,' Do Says
50:28 - Khiem Do, who helps oversee about $60 billion as Hong Kong-based head of Asian multi-asset strategy at Baring Asset Management Ltd., talks about China's economy, stock market, and central bank policy. He speaks with Angie Lau on Bloomberg Television's "Asia Edge." (Source: Bloomberg)
  • Europe Isn’t In a Strong Position to Let Greece Go: Do
  • Chinese Airline Stocks Soar on Low Fuel Prices
  • Five Ways the Grexit Could Happen